Multiple Bottom Chart Pattern Is Formed By CEMEX, S.A.B. de C.V. (CX) at $4.76

CEMEX, S.A.B. de C.V. (NYSE:CX) Corporate Logo

Multiple bottoms technical setup was formed by CEMEX, S.A.B. de C.V. (CX) with $4.52 target or 5.00 % below today’s $4.76 stock price. On Apr, 3 the multiple bottoms technical setup was reported by Finviz.com. $358.25 million less could be CX valuation at $4.52 stock price.

The last price was $4.76.It’s downtrending since April 3, 2018 and is 30.49% up. CX underperformed by 34.86% the S&P 500.

CEMEX, S.A.B. de C.V. (NYSE:CX) Ratings Coverage

In total 2 analysts cover Cemex (NYSE:CX). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. 100% are bullish. With $8 highest and $6.7 lowest price target Cemex has $7.35 average price target or 54.41% above the current ($4.76) price. 2 are the (NYSE:CX)’s analyst reports since October 26, 2018 according to StockzIntelligence Inc. The company rating was maintained by Barclays Capital on Friday, October 26. On Wednesday, March 13 Credit Suisse maintained CEMEX, S.A.B. de C.V. (NYSE:CX) rating. Credit Suisse has “Buy” rating and $6.7 target.

For more CEMEX, S.A.B. de C.V. (NYSE:CX) news published recently go to: Benzinga.com, Businesswire.com, Streetinsider.com, Seekingalpha.com or Nasdaq.com. The titles are as follows: “Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial – Benzinga” published on April 02, 2019, “CEMEX Reaches Binding Agreement to Divest Aggregates and Ready-Mix Assets in Germany – Business Wire” on March 19, 2019, “Cemex SA (CX) to Sell White Cement Business for $180 Million – StreetInsider.com” with a publish date: March 20, 2019, “CEMEX commences stock repurchase program – Seeking Alpha” and the last “7 Stocks From Around the World That Beat U.S. Stocks – Nasdaq” with publication date: April 01, 2019.

CEMEX, S.A.B. de C.V. (NYSE:CX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.